Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole Bertin

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Biomedicines|November 27, 2021
Plasma Lipoprotein(a) Levels as Determinants of Arterial Stiffening in HypertensionGabriele Brosolo, Andrea Da Porto, Luca Bulfone, et al.
Neuromuscular Disorders : NMD|April 24, 2017
Investigation on acute effects of enzyme replacement therapy and influence of clinical severity on physiological variables related to exercise tolerance in patients with late onset Pompe diseaseAnnalisa Sechi, Desy Salvadego, Alessandro Da Ponte, et al.
European Journal of Pharmacology|November 8, 2024
The role for ω-3 polyunsaturated and short chain fatty acids in hypertension: An updated view on the interaction with gut microbiotaGabriele Brosolo, Andrea Da Porto, Stefano Marcante, et al.
International Journal of Molecular Sciences|June 10, 2023
Omega-3 Fatty Acids in Arterial Hypertension: Is There Any Good News?Gabriele Brosolo, Andrea Da Porto, Stefano Marcante, et al.
International Journal of Molecular Sciences|September 9, 2023
Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?Gabriele Brosolo, Andrea Da Porto, Stefano Marcante, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Biomedicines|November 27, 2021
Plasma Lipoprotein(a) Levels as Determinants of Arterial Stiffening in HypertensionGabriele Brosolo, Andrea Da Porto, Luca Bulfone, et al.
Neuromuscular Disorders : NMD|April 24, 2017
Investigation on acute effects of enzyme replacement therapy and influence of clinical severity on physiological variables related to exercise tolerance in patients with late onset Pompe diseaseAnnalisa Sechi, Desy Salvadego, Alessandro Da Ponte, et al.
European Journal of Pharmacology|November 8, 2024
The role for ω-3 polyunsaturated and short chain fatty acids in hypertension: An updated view on the interaction with gut microbiotaGabriele Brosolo, Andrea Da Porto, Stefano Marcante, et al.
International Journal of Molecular Sciences|June 10, 2023
Omega-3 Fatty Acids in Arterial Hypertension: Is There Any Good News?Gabriele Brosolo, Andrea Da Porto, Stefano Marcante, et al.
International Journal of Molecular Sciences|September 9, 2023
Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?Gabriele Brosolo, Andrea Da Porto, Stefano Marcante, et al.
Pageof 3